Pre-Clinical Lessons We Wish We’d Known
What seasoned medtech developers would do differently — and why it matters
Pre-clinical studies and early-stage trials are some of the most challenging — and expensive — milestones in medical device development. Yet, many teams encounter avoidable setbacks that could have been prevented with strategic foresight and practical lessons learned from experience.
In the webinar “Pre-Clinical Lessons We Wish We’d Known,” three experienced medtech professionals — Joris van der Heijden (Concept Development Lead), Paul Hulme (Human Factors Engineer), and Nick Allan (Bio Services Manager) from StarFish Medical — share candid stories, real-world challenges, and the pivotal pre-clinical insights they’ve gained over decades of medical device development.
Key Takeaways from the Webinar:
- Design with the drug container in mind — Why selecting or accommodating the right primary drug container is critical for pharma partnerships and market acceptance.
- Minimizing use errors through user-centered design — How real-world user behavior and stress conditions impact device performance, and why early usability testing is essential.
- Lessons in IFU reliance and training — Why you can’t count on users reading instructions, and how hands-on training and competency checks can mitigate risk.
- Packaging and labeling pitfalls — Surprising findings on what users actually notice on packaging (and what they don’t) and how simple design changes can improve safety and compliance.
- The risks of last-minute design changes before trials — A cautionary story from clinical research where small hardware adjustments led to major setbacks.
- Pre-clinical validation strategies that work — How simulation models, imaging studies, and stepwise testing can reduce uncertainty before entering costly clinical trials.
Whether you’re an engineer, program manager, clinical lead, or regulatory professional, this webinar offers practical, hard-earned advice to help you avoid delays, reduce risk, and position your medical device for clinical and market success.
Speakers
- Joris van der Heijden, Concept Development Lead, StarFish Medical
- Paul Hulme, Human Factors Engineer, StarFish Medical
- Nick Allan, Bio Services Manager, StarFish Medical
Pre-Clinical Lessons We Wish We’d Known
Insights to help you avoid costly mistakes — before clinical trials begin.
Related Resources
In this Bio Break episode, Nick and Nigel explore why some GLP-1 drugs are taken daily while others last a full week, and what drives that difference at a molecular level.
Choosing the right project estimation approach can make or break a medical device program. Learn when to use a gut feel, rough order of magnitude, or detailed estimate to balance speed, accuracy, and risk.
Ozempic is a synthetic version of a hormone your body already makes. That hormone is called GLP-1 (glucagon-like peptide-1), and your intestine releases it naturally when food arrives.
Accelerated aging in medical devices is a testing method used to estimate how a product will perform over time by exposing it to elevated conditions, most often heat. In simple terms, it is a way to simulate months or years of aging in a much shorter timeframe.